内視鏡的逆行性胆管膵管造影法の市場：製品、手技、エンドユーザー別-2025-2030年の世界予測

内視鏡的逆行性胆管膵管造影法市場は、2023年に19億1,000万米ドルと評価され、2024年には20億5,000万米ドルに達すると予測され、CAGR 7.59％で成長し、2030年には32億米ドルになると予測されています。

内視鏡的逆行性胆管膵管造影法（ERCP）は、胆道系や膵管系の状態を診断・治療するために、内視鏡と透視を組み合わせた特殊な技術です。特に、胆石、狭窄、嚢胞、がん、その他の閉塞などの症状に対して必要であり、消化器内科では欠かせない検査です。ERCPは主に病院や専門クリニックで行われ、総合的な消化器系の評価を必要とする患者にサービスを提供しています。膵・胆道系疾患の有病率が高まる中、市場は高齢化と早期診断・治療オプションに対する意識の高まりの影響を受けています。低侵襲技術の開発や画像ソリューションの強化といった技術の進歩が、大きな成長を後押ししています。さらに、アジアとラテンアメリカの新興市場は、ヘルスケアインフラの改善と医療ツーリズムの拡大により、大きなビジネスチャンスをもたらしています。しかし、高額な費用、熟練した専門家の必要性、処置後の膵炎などの合併症のリスクといった制約があり、これが普及を妨げる可能性があります。課題としては、様々な地域における厳しい規制環境や償還の問題が挙げられます。市場機会を生かすために、企業は機器の小型化、より正確な診断手順の市場開拓、手順の安全性と有効性を向上させるためのヘルスケアプロバイダーとの連携などの技術革新に注力すべきです。さらに、開業医のスキルを向上させる教育プログラムを育成することで、ERCPの採用を拡大することができます。市場は競争激化の傾向にあり、技術ポートフォリオと地理的プレゼンスの拡大を目指す企業にとって、戦略的提携や合併が頻繁に行われるようになっています。人工知能と機械学習における革新は、診断と治療をさらに個別化する可能性があり、この分野を有望な研究分野にしています。全体として、ERCP市場は、利害関係者が障壁を効果的に乗り越え、医療技術と手技の実践における最先端の技術革新を活用すれば、成長する態勢が整っています。

市場力学：急速に進化する内視鏡的逆行性胆管膵管造影法市場の主要市場インサイトを公開

内視鏡的逆行性胆管膵管造影法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 消化器疾患および慢性胆道疾患の有病率の増加
  • 世界の医療インフラの充実によるヘルスケア支出の増加
  • 高度な内視鏡技術に対する消費者の意識の高まりと相まって、低侵襲手術に対する嗜好の高まり
• 市場抑制要因
  • 内視鏡的逆行性胆管膵管造影法機器に関連する高コスト
• 市場機会
  • 内視鏡手術の進歩のための多額の投資による研究開発活動
  • 内視鏡的逆行性胆管膵管造影法ソリューションの導入が急増中であり、政府が積極的な動きを見せていること
• 市場の課題
  • 世界中で熟練した専門家や訓練を受けた内視鏡医が不足していること

ポーターの5つの力：内視鏡的逆行性胆管膵管造影法市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：内視鏡的逆行性胆管膵管造影法市場における外部からの影響の把握

外部マクロ環境要因は、内視鏡的逆行性胆管膵管造影法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析内視鏡的逆行性胆管膵管造影法市場における競合情勢の把握

内視鏡的逆行性胆管膵管造影法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス内視鏡的逆行性胆管膵管造影法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、内視鏡的逆行性胆管膵管造影法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨内視鏡的逆行性胆管膵管造影法市場における成功への道筋を描く

内視鏡的逆行性胆管膵管造影法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 胃腸疾患および慢性胆道疾患の罹患率の増加
    • ヘルスケア費の増加と世界規模でのヘルスケアインフラの強化
    • 低侵襲手術への嗜好の高まりと、高度な内視鏡技術に対する消費者の意識の高まり
  • 抑制要因
    • 内視鏡的逆行性胆管膵管造影法デバイスに関連する高コスト
  • 機会
    • 内視鏡手術の進歩のために多額の投資を伴う重要な研究開発活動
    • 政府の好意的な措置により、内視鏡的逆行性胆管膵管造影法ソリューションの導入が急増中
  • 課題
    • 世界中で熟練した専門家と訓練を受けた内視鏡医が不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 内視鏡的逆行性胆管膵管造影法の市場：製品別

• 内視鏡
• 内視鏡治療装置
  • バルーン
  • バスケット
  • カニューレ
  • カテーテル
  • 鉗子
  • ガイドワイヤー
  • 砕石器
  • スネア
  • 括約筋切開術
  • ステント
• エネルギーデバイス
• 可視化システム

第7章 内視鏡的逆行性胆管膵管造影法の市場手順別

• 胆管拡張症
• 胆道括約筋切開術
• 胆管ステント
• 膵管拡張
• 膵管ステント留置術
• 膵括約筋切開術

第8章 内視鏡的逆行性胆管膵管造影法の市場：エンドユーザー別

• 外来手術センターおよびクリニック
• 病院

第9章 南北アメリカの内視鏡的逆行性胆管膵管造影法の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の内視鏡的逆行性胆管膵管造影法の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの内視鏡的逆行性胆管膵管造影法の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• CONMED Corporation
• Cook Group Incorporated
• Fujifilm Holdings Corporation
• Johnson & Johnson Services, Inc.
• KARL STORZ SE & Co. KG
• Machida Endoscope Co., Ltd
• Medi-Globe GmbH
• Medtronic PLC
• Merit Medical Systems, Inc.
• Olympus Corporation
• Ottomed Endoscopy
• PENTAX Medical
• Richard Wolf GmbH
• Smith & Nephew PLC
• STERIS
• Stryker Corporation

LIST OF FIGURES

• FIGURE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET RESEARCH PROCESS
• FIGURE 2. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET DYNAMICS
• TABLE 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BASKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY FORCEPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LITHOTRIPTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SNARES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY DILATATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SPHINCTEROTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY STENTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT DILATATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT STENTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SPHINCTEROTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGERY CENTRES & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 95. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 99. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 103. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 106. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 107. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 111. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 120. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 124. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 128. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 131. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 132. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 136. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 140. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 144. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 148. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 152. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 156. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 160. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 164. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 168. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 171. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 172. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 180. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 184. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 188. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 191. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 192. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 200. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 202. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023

The Endoscopic Retrograde Cholangiopancreatography Market was valued at USD 1.91 billion in 2023, expected to reach USD 2.05 billion in 2024, and is projected to grow at a CAGR of 7.59%, to USD 3.20 billion by 2030.

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a specialized technique combining endoscopy and fluoroscopy to diagnose and treat conditions of the biliary or pancreatic ductal systems. The procedure is particularly necessary for conditions like gallstones, strictures, cysts, cancer, and other blockages, making it indispensable in gastroenterology. ERCP is applied predominantly within hospitals and specialized clinics, serving patients who require comprehensive digestive system evaluations. Amidst the increasing prevalence of pancreatic and biliary diseases, the market is influenced by an aging population and growing awareness about early diagnosis and treatment options. Technological advancements, such as the development of minimally invasive techniques and enhanced imaging solutions, drive significant growth. Moreover, emerging markets in Asia and Latin America present substantial opportunities due to improving healthcare infrastructure and expanding medical tourism. However, the market encounters limitations such as high costs, the need for skilled professionals, and the risk of complications like pancreatitis post-procedure, which might deter its adoption. Challenges include stringent regulatory environments and reimbursement issues in various regions. To capitalize on market opportunities, businesses should focus on innovations in equipment miniaturization, development of more accurate diagnostic procedures, and collaborations with healthcare providers to improve procedural safety and efficacy. Moreover, fostering educational programs to enhance practitioner skills can broaden the adoption of ERCP. The market tends towards competitive consolidation, with strategic alliances and mergers becoming more frequent for firms aiming to expand their technology portfolios and geographic presence. Innovations in artificial intelligence and machine learning could further personalize diagnosis and treatment, making this a promising area for research. Overall, the ERCP market is poised for growth, provided stakeholders navigate barriers effectively and leverage cutting-edge innovations in medical technology and procedural practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of gastrointestinal and chronic biliary disorders
  • Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
  • Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
• Market Restraints
  • High costs associated with endoscopic retrograde cholangiopancreatography devices
• Market Opportunities
  • Significant research and development activities with heavy investments for advancement of endoscopic procedures
  • Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
• Market Challenges
  • Scarcity of skilled professionals and trained endoscopists across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Endoscopic Retrograde Cholangiopancreatography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endoscopic Retrograde Cholangiopancreatography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endoscopic Retrograde Cholangiopancreatography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endoscopic Retrograde Cholangiopancreatography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endoscopic Retrograde Cholangiopancreatography Market

A detailed market share analysis in the Endoscopic Retrograde Cholangiopancreatography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endoscopic Retrograde Cholangiopancreatography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endoscopic Retrograde Cholangiopancreatography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endoscopic Retrograde Cholangiopancreatography Market

A strategic analysis of the Endoscopic Retrograde Cholangiopancreatography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endoscopic Retrograde Cholangiopancreatography Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd, Medi-Globe GmbH, Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Ottomed Endoscopy, PENTAX Medical, Richard Wolf GmbH, Smith & Nephew PLC, STERIS, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Endoscopic Retrograde Cholangiopancreatography Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Endoscopes, Endotherapy Devices, Energy Devices, and Visualization Systems. The Endotherapy Devices is further studied across Balloons, Baskets, Cannulas, Catheters, Forceps, Guiding Wires, Lithotripter, Snares, Sphincterotomes, and Stents.
• Based on Procedure, market is studied across Biliary Dilatation, Biliary Sphincterotomy, Biliary Stenting, Pancreatic Duct Dilatation, Pancreatic Duct Stenting, and Pancreatic Sphincterotomy.
• Based on End-User, market is studied across Ambulatory Surgery Centres & Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of gastrointestinal and chronic biliary disorders
    • 5.1.1.2. Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
    • 5.1.1.3. Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with endoscopic retrograde cholangiopancreatography devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant research and development activities with heavy investments for advancement of endoscopic procedures
    • 5.1.3.2. Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
  • 5.1.4. Challenges
    • 5.1.4.1. Scarcity of skilled professionals and trained endoscopists across the globe
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Endoscopic Retrograde Cholangiopancreatography Market, by Product

• 6.1. Introduction
• 6.2. Endoscopes
• 6.3. Endotherapy Devices
  • 6.3.1. Balloons
  • 6.3.2. Baskets
  • 6.3.3. Cannulas
  • 6.3.4. Catheters
  • 6.3.5. Forceps
  • 6.3.6. Guiding Wires
  • 6.3.7. Lithotripter
  • 6.3.8. Snares
  • 6.3.9. Sphincterotomes
  • 6.3.10. Stents
• 6.4. Energy Devices
• 6.5. Visualization Systems

7. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure

• 7.1. Introduction
• 7.2. Biliary Dilatation
• 7.3. Biliary Sphincterotomy
• 7.4. Biliary Stenting
• 7.5. Pancreatic Duct Dilatation
• 7.6. Pancreatic Duct Stenting
• 7.7. Pancreatic Sphincterotomy

8. Endoscopic Retrograde Cholangiopancreatography Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centres & Clinics
• 8.3. Hospitals

9. Americas Endoscopic Retrograde Cholangiopancreatography Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun Melsungen AG
• 2. Becton, Dickinson and Company
• 3. Boston Scientific Corporation
• 4. CONMED Corporation
• 5. Cook Group Incorporated
• 6. Fujifilm Holdings Corporation
• 7. Johnson & Johnson Services, Inc.
• 8. KARL STORZ SE & Co. KG
• 9. Machida Endoscope Co., Ltd
• 10. Medi-Globe GmbH
• 11. Medtronic PLC
• 12. Merit Medical Systems, Inc.
• 13. Olympus Corporation
• 14. Ottomed Endoscopy
• 15. PENTAX Medical
• 16. Richard Wolf GmbH
• 17. Smith & Nephew PLC
• 18. STERIS
• 19. Stryker Corporation